Clown Care for Botulinum Toxin (BTX)
NCT01377883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2018-12-31
Summary
Children with cerebral palsy (CP) undergo multiple painful procedures such as Botulinum toxin (BTX) injections that are administered several times a year. While clown care reduces preoperative anxiety, its effect on painful procedures has not been assessed. We hypothesized that medical clowning reduces pain and anxiety during BTX injections.
Conditions
- Cerebral Palsy
- Pain
Interventions
- OTHER
-
standard
Preparation and information regarding the BTX procedure: placing EMG electrodes, wiping the area with an alcohol swab, cooling with ethyl chloride, needle insertion into the muscle and the importance of EMG noise. Injection performed under EMG guidance. Two sites of injection per muscle were used to enhance diffusion. The child could often see the procedure when the upper limb was treated but not during lower limb injections. Memory change and positive reinforcement: Following the BTX injection, the medical staff present spoke to the child positively and offered prizes Volunteer attendance: In the daycare unit there are young volunteers routinely present, assisting with technical aspects of the procedure.
- BEHAVIORAL
-
clown care
Cognitive coping Imagery Empowerment Reflecting emotions
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-06-30
More Related Trials
-
BOTOX® Treatment in Pediatric Lower Limb Spasticity
NCT01603628 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment and Management of Post-Stroke Spasticity With Botulinum Toxin-A
NCT01751373 ·Status: COMPLETED ·Phase: NA
-
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
NCT06583343 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Functional Outcomes of Botulinum Toxin A Injections to Hamstrings in Flexed Knee Gait in Cerebral Palsy
NCT00261131 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity
NCT00723866 ·Status: COMPLETED ·Phase: NA
-
Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral Palsy
NCT00173745 ·Status: UNKNOWN ·Phase: NA
-
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
NCT00133861 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early BOTOX After Spinal Cord Injury
NCT06793683 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral Palsy
NCT01787344 ·Status: COMPLETED ·Phase: PHASE3
-
Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
NCT07303582 ·Status: RECRUITING ·Phase: PHASE4
-
Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
NCT00320281 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
NCT01905683 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
NCT01603615 ·Status: COMPLETED ·Phase: PHASE3
-
Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery
NCT00412035 ·Status: COMPLETED ·Phase: PHASE3
-
Muscle Elastography in Spastic Cerebral Palsy
NCT03112434 ·Status: COMPLETED
-
Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy
NCT03616067 ·Status: TERMINATED ·Phase: PHASE3
-
Sevoflurane and Propofol for Botulinum Toxin Injection
NCT05505123 ·Status: WITHDRAWN ·Phase: NA
-
JCP Study of Investigation of Patient Background Characteristics
NCT01332474 ·Status: COMPLETED
-
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
NCT01603641 ·Status: COMPLETED ·Phase: PHASE3
-
Neurotoxin and Physical Therapy
NCT02177617 ·Status: COMPLETED ·Phase: PHASE4
-
Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity
NCT01091727 ·Status: COMPLETED ·Phase: PHASE3
-
Spread And Effectiveness Of Botulinum Neurotoxin A In Spastic Equinus In Cerebral Palsy
NCT01276015 ·Status: COMPLETED ·Phase: PHASE4
-
Validity of Bispectral Index Monitoring During Deep Sedation
NCT02096549 ·Status: COMPLETED
-
Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder
NCT01716624 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Treatment in Pediatric Upper Limb Spasticity
NCT01603602 ·Status: COMPLETED ·Phase: PHASE3